Analytical Data
-
基因名
TATDN3
- Application
-
别名
TATDN3；Putative deoxyribonuclease TATDN3
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q17R31
-
表达区间
1-274aa
-
氨基酸序列
MGSSHHHHHH SSGLVPRGSH MGSHMRAAGV GLVDCHCHLS APDFDRDLDD VLEKAKKANV VALVAVAEHS GEFEKIMQLS ERYNGFVLPC LGVHPVQGLP PEDQRSVTLK DLDVALPIIE NYKDRLLAIG EVGLDFSPRF AGTGEQKEEQ RQVLIRQIQL AKRLNLPVNV HSRSAGRPTI NLLQEQGAEK VLLHAFDGRP SVAMEGVRAG YFFSIPPSII RSGQKQKLVK QLPLTSICLE TDSPALGPEK QVRNEPWNIS ISAEYIAQVK GISVEEVIEV TTQNALKLFP KLRHLLQK
-
分子量
33 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
TATDN3, a member of the TAT (Tat-deficient) family of proteins, has garnered increasing attention in recent years due to its potential role in various biological processes and disease mechanisms. Researchers have identified TATDN3 as a protein involved in the regulation of gene expression, cellular signaling, and response to stress, particularly in the context of cancer and neurodegenerative diseases. Studies suggest that TATDN3 may interact with key transcription factors and signaling pathways, influencing cell proliferation and apoptosis. Moreover, its expression levels have been correlated with tumor progression and patient prognosis, indicating its significance as a potential biomarker. The investigation of TATDN3’s structure, function, and interactions at the molecular level remains crucial for understanding its role in health and disease. Recombinant protein studies of TATDN3 aim to elucidate its mechanisms and explore therapeutic applications, possibly leading to novel strategies for cancer treatment and other related conditions. Given these insights, ongoing research continues to explore the full potential of TATDN3, highlighting its relevance in molecular biology and translational medicine.
